Switch to:
More From Other Websites
4 Top-Rated Drugmakers Reporting Earnings This Week Apr 26 2015
2:15 am AbbVie: FDA grants priority review to AbbVie for investigational, all-oral, interferon-free... Apr 26 2015
Bristol-Myers says hepatitis C drug combination succeeds in study Apr 25 2015
Enanta Pharmaceuticals Announces Preliminary Data from AbbVie’s Phase 3b RUBY-I Study in Chronic... Apr 25 2015
AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic... Apr 25 2015
AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic... Apr 25 2015
Inversion Deals Aren’t Dead, They’re Just More Low-Key: Real M&A Apr 25 2015
Inversion Deals Aren't Dead, They're Just More Low-Key Apr 25 2015
AbbVie's HCV Cocktail Treatment Under FDA Priority Review - Analyst Blog Apr 24 2015
Eli Lilly (LLY) Earnings Analysis: By the Numbers Apr 24 2015
AbbVie Hepatitis C Drug Granted Priority FDA Review Apr 24 2015
AbbVie (ABBV) Earnings Report: Q1 2015 Conference Call Transcript Apr 24 2015
U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for... Apr 24 2015
Merck oral hepatitis C regimen shows 95 pct cure rate Apr 24 2015
U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for... Apr 23 2015
Biogen Earnings Preview: What To Look For Apr 23 2015
AbbVie Profit Rises on Broad Sales Growth Apr 23 2015
Doomsday Plan for AbbVie Means Preserving Profits at All Costs Apr 23 2015
AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed Apr 23 2015
AbbVie Beats Earnings on Humira and HCV Sales, Ups View - Analyst Blog Apr 23 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK